Biowell CLA 1000
Natural health product licensed in Canada
- Other names
- AGONY CLA 1000mg, Biogenique CLA 1000, Bioway CLA 1000 mg, CLA 1000, Handpick CLA 1000, Medicap CLA 1000, ORGEN SPORTS CLA 1000, OSN1 CLA 1000, TRASIMAX CLA, TRUSIMAX CLA, Urban Nutrition CLA
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80070240
- Status
- Active licence
- Licence date
- 13 June 2016
- Revision date
- 12 February 2026
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide linoléique conjugué | 1,000 milligramme | Not calculated |
Non-medicinal ingredients
Amidon de maïs modifié, Glycérine, Huile de citron, distillée, Carraghénine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 4 Tous les jours |
Uses authorised in Canada
May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity. May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if your goal is to achieve weight loss. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are obese or have cardiovascular disease (CVD) risk factors.
- Effets indésirables connus
Some people may experience gastrointestinal upset.
- Contre-indications
Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance.
Source
Official Health Canada record, licence 80070240
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.